Persistent Asset Partners »

Tg Therapeutics shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Tg Therapeutics shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $24k 265 91.32

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Molina Healthcare (MOH)
Anthem (ELV)
Intel Corporation (INTC)
Axt (AXTI)
Terns Pharmaceuticals (TERN)
Sandisk Corp (SNDK)
Abivax Sa Sponsored Ads (ABVX)
Johnson & Johnson (JNJ)
Brightspring Health Svcs (BTSG)
Viking Therapeutics Call Call Option
Viking Therapeutics (VKTX)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Nebius Group Shs Class A (NBIS)

View all positions for Persistent Asset Partners

Top funds holding Tg Therapeutics

Group One Trading
Simplex Trading
IMC-Chicago
Persistent Asset Partners

View all funds holding Tg Therapeutics